Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117202) titled 'Prospective, Multicenter, Randomized, Controlled, Double-Blind Study: Analysis of the Efficacy of Enarodustat in Treating Anemia in Patients with Renal Insufficiency due to Multiple Myeloma' on Jan. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Condition:
Multiple myeloma associated anemia
Intervention:
Control group:Placebo
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Control group:77;Research group:77;
Countries of Recruitment:
China
To ...